Local recurrence is a frequent event after surgical resection for cholangiocarcinoma; to achieve better control radiotherapy has been proposed, alone or associated with chemotherapy [1], although other authors have suggested applying chemotherapy alone after surgical resection. However, the role of these treatments is not standardized throughout the various centers that manage biliary neoplasms.


Radiat Oncol Biol Phys Gallbladder Carcinoma Chemoradiation Therapy Hilar Cholangiocarcinoma Intrahepatic Cholangiocarcinoma 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Chari RS, Anderson CA, Bavarese DMF (2003) Treatment of cholangiocarcinoma. I. In: Rose BD (ed) UpToDate. UpToDate. Wellesley, MA, pp [AQ3]Google Scholar
  2. 2.
    Pitt HA, Broelsch C, Fong Y et al (2003) Adjuvant therapy for biliary malignancies: international trends and possibilities. J Gastrointest Surg 7:309ACrossRefGoogle Scholar
  3. 3.
    Nagino M, Nimura Y (2006) Perihilar cholangiocarcinoma with emphasis on presurgical management. In: Blumgart LH (ed). Surgery of the liver, biliary tract, and pancreas. 4 edn. Saunders Elsevier, Philadelphia, pp 804–814Google Scholar
  4. 4.
    Takada T, Amano H, Yasuda H et al; Study Group of Surgical Adjuvant Therapy for Carcinomas of the Pancreas and Biliary Tract (2002) Is postoperative adjuvant chemotherapy useful for gallbladder carcinoma? A phase III multicenter prospective randomized controlled trial in patients with resected pancreaticobiliary carcinoma. Cancer 95(8):1685–1695PubMedCrossRefGoogle Scholar
  5. 5.
    Khan SA, Thomas HC, Davidson BR, Taylor-Robinson SD (2005) Cholangiocarcinoma. Lancet 366(9493):1303–1314PubMedCrossRefGoogle Scholar
  6. 6.
    Cameron JL, Pitt HA, Zinner MJ et al (1990) Management of proximal cholangiocarcinomas by surgical resection and radiotherapy. Am J Surg 159(1):91–97; discussion 97–98PubMedCrossRefGoogle Scholar
  7. 7.
    Pitt HA, Nakeeb A, Abrams RA et al (1995) Perihilar cholangiocarcinoma. Postoperative radiotherapy does not improbe survival. Ann Surg 221(6):788–797; discussion 797–798PubMedCrossRefGoogle Scholar
  8. 8.
    Kamada T, Saitou H, Takamura A et al (1996) The role of radiotherapy in the management of extrahepatic bile duct cancer: an analysis of 145 consecutive patients treated with intraluminal and/or external beam radiotherapy. Int J Radiat Oncol Biol Phys 34(4):767–774PubMedCrossRefGoogle Scholar
  9. 9.
    Todoroki T, Ohara K, Kawamoto T et al (2000) Benefits of adjuvant radiotherapy after radical resection of locally advanced main hepatic duct carcinoma. Int J Radiat Oncol Biol Phys 46(3):581–587PubMedCrossRefGoogle Scholar
  10. 10.
    Gerhards MF, van Gulik TM, Gonzalez D et al (2003) Results of postoperative radiotherapy for resectable hilar cholangiocarcinoma. World J Surg 27(2):173–179PubMedGoogle Scholar
  11. 11.
    Kim S, Kim SW, Bang YJ et al (2002) Role of postoperative radiotherapy in the management of extrahepatic bile duct cancer. Int J Radiat Oncol Biol Phys 54(2):414–419PubMedCrossRefGoogle Scholar
  12. 12.
    Robertson JM, Lawrence TS, Andrews JC et al (1997) Long-term results of hepatic artery fluorodeoxyuridine and conformal radiation therapy for primary hepatobiliary cancers. Int J Radiat Oncol Biol Phys 37(2):325–330PubMedCrossRefGoogle Scholar
  13. 13.
    Whittington R, Neuberg D, Tester WJ et al (1995) Protracted intravenous fluorouracil infusion with radiation therapy in the management of localized pancreaticobiliary carcinoma: a phase I Eastern Cooperative Oncology Group Trial. J Clin Oncol 13:227–232PubMedGoogle Scholar
  14. 14.
    Serafini FM, Sachs D, Bloomston M et al (2001) Location, not staging, of cholangiocarcinoma determines the role for adjuvant chemoradiation therapy. Am Surg 67(9):839–843; discussion 843–844PubMedGoogle Scholar
  15. 15.
    Figueras J, Llado L, Valls C et al (2000) Changing strategies in diagnosis and management of hilar cholangiocarcinoma. Liver Transpl 6(6):786–794PubMedGoogle Scholar
  16. 16.
    Nakeeb A, Tran KQ, Black MJ et al (2002) Improved survival in resected biliary malignancies. Surgery 132(4):555–563; discussion 563–564PubMedCrossRefGoogle Scholar
  17. 17.
    McMasters KM, Tuttle TM, Leach SD et al (1997) Neoadjuvant chemoradiation for extrahepatic cholangiocarcinoma. Am J Surg 174(6):605–608; discussion 608–609PubMedCrossRefGoogle Scholar
  18. 18.
    Sudan D, DeRoover A, Chinnakotla S et al (2002) Radiochemotherapy and transplantation allow long-term survival for nonresectable hilar cholangiocarcinoma. Am J Transplant 2(8):774–779PubMedCrossRefGoogle Scholar
  19. 19.
    De Vreede I, Steers JL, Burch PA et al (2000) Prolonged disease-free survival after orthotopic liver transplantation plus adjuvant chemoirradiation for cholangiocarcinoma. Liver Transpl 6(3):309–316PubMedCrossRefGoogle Scholar
  20. 20.
    Heimbach JK, Gores GJ, Nagorney DM, Rosen CB (2006) Liver transplantation for perihilar cholangiocarcinoma after aggressive neoadjuvant therapy: a new paradigm for liver and biliary malignancies? Surgery 140(3):331–334PubMedCrossRefGoogle Scholar
  21. 21.
    Wiedmann M, Caca K, Berr F et al (2003) Neoadjuvant photodynamic therapy as a new approach to treating hilar cholangiocarcinoma: a phase II pilot study. Cancer 97(11):2783–2790PubMedCrossRefGoogle Scholar

Copyright information

© Springer 2008

Personalised recommendations